Cargando…
Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive us...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339424/ https://www.ncbi.nlm.nih.gov/pubmed/30658683 http://dx.doi.org/10.1186/s13104-019-4053-2 |
_version_ | 1783388635961229312 |
---|---|
author | Reta, Mebratu Mitiku Tessema, Gizachew Assefa Shiferaw, Getachew |
author_facet | Reta, Mebratu Mitiku Tessema, Gizachew Assefa Shiferaw, Getachew |
author_sort | Reta, Mebratu Mitiku |
collection | PubMed |
description | OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive use among HIV positive women at University of Gondar Hospital, North West Ethiopia. RESULT: The prevalence of dual contraceptive use was found to be 13.2% (95% CI 10.5, 16.0). Partner involvement in post-test counseling [AOR = 3.11 (95% CI = 1.74, 5.57)], open partner discussion on using dual contraceptive [AOR = 7.84, 95% CI (4.26, 14.42)], provision of counseling about dual contraception [AOR = 6.56, 95% CI (3.54, 12.18)], age 18–24 years [AOR = 4.79, 95% CI (1.72, 13.32)], age 25–34 years [AOR = 1.97, 95% CI (1.01, 3.85)] and being a housewife [AOR = 4.38, 95% CI (1.89, 10.16)] were significant factors associated with dual contraceptive use. The prevalence of dual contraceptive use was low. This shows, there is a need to in promote partner involvement in HIV testing and counseling by offering counseling session in a couple-basis. It is also necessary for programmers to routinely focus on provision of dual contraception for HIV-infected women and Integration of family planning into HIV care follow-up clinic need to be strengthened. |
format | Online Article Text |
id | pubmed-6339424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63394242019-01-23 Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia Reta, Mebratu Mitiku Tessema, Gizachew Assefa Shiferaw, Getachew BMC Res Notes Research Note OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive use among HIV positive women at University of Gondar Hospital, North West Ethiopia. RESULT: The prevalence of dual contraceptive use was found to be 13.2% (95% CI 10.5, 16.0). Partner involvement in post-test counseling [AOR = 3.11 (95% CI = 1.74, 5.57)], open partner discussion on using dual contraceptive [AOR = 7.84, 95% CI (4.26, 14.42)], provision of counseling about dual contraception [AOR = 6.56, 95% CI (3.54, 12.18)], age 18–24 years [AOR = 4.79, 95% CI (1.72, 13.32)], age 25–34 years [AOR = 1.97, 95% CI (1.01, 3.85)] and being a housewife [AOR = 4.38, 95% CI (1.89, 10.16)] were significant factors associated with dual contraceptive use. The prevalence of dual contraceptive use was low. This shows, there is a need to in promote partner involvement in HIV testing and counseling by offering counseling session in a couple-basis. It is also necessary for programmers to routinely focus on provision of dual contraception for HIV-infected women and Integration of family planning into HIV care follow-up clinic need to be strengthened. BioMed Central 2019-01-18 /pmc/articles/PMC6339424/ /pubmed/30658683 http://dx.doi.org/10.1186/s13104-019-4053-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note Reta, Mebratu Mitiku Tessema, Gizachew Assefa Shiferaw, Getachew Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title | Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title_full | Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title_fullStr | Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title_full_unstemmed | Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title_short | Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia |
title_sort | prevalence of dual contraceptive use and associated factors among hiv positive women at university of gondar hospital, northwest ethiopia |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339424/ https://www.ncbi.nlm.nih.gov/pubmed/30658683 http://dx.doi.org/10.1186/s13104-019-4053-2 |
work_keys_str_mv | AT retamebratumitiku prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia AT tessemagizachewassefa prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia AT shiferawgetachew prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia |